金奧博(002917.SZ):2023年度淨利潤預增295.91%至394.89%
格隆匯1月18日丨金奧博(002917.SZ)公佈2023年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利10,000萬元至12,500萬元,比上年同期增長295.91%至394.89%;扣除非經常性損益後的淨利潤盈利9,200萬元至11,700萬元,比上年同期增長541.17%至715.40%基;本每股收益盈利0.29元/股至0.36元/股。
報吿期內,公司緊密圍繞公司發展戰略和經營管理目標開展各項運營工作,不斷加強市場拓展,民爆器材和關鍵原輔材料實現產銷量同比增加,帶動業績增長。同時,公司通過採取一系列措施優化內部管理,加強成本控制,毛利率得到提升,促進公司效益增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.